Regulatory Affairs Certification (RAC) Practice Exam

To export a Class III medical device to Australia, a U.S. company must engage in specific regulatory actions that comply with both U.S. FDA requirements and Australian Therapeutic Goods Administration (TGA) regulations. Sending a Simple Notification to the FDA and obtaining an 802 Certificate of Exportability is the correct course of action because this certificate demonstrates compliance with the FDA's export requirements for products that are not approved for commercial distribution within the U.S.

The 802 Certificate of Exportability indicates that the device meets the necessary regulatory standards for export, even if it hasn't undergone the full approval process in the U.S. This facilitates the process of legally exporting the device while providing assurance to foreign regulatory authorities, like the TGA, of adherence to necessary safety and efficacy standards.

This action allows the U.S. company to proceed with their exportation efforts with the appropriate documentation, reducing risks associated with non-compliance during international distribution.